First seen by DFX
Sep 15, 2026
date not stated
Oxford Bioscience III Corporation: INSTITUTIONAL_VC -> MICRO_VC (venture manager, reported GAV $20.6M across 2 vehicles)
Oxford Bioscience Partners (adjunct) III L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners (adjunct) II L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners (bermuda) II Limited Partnership no longer reported on Form ADV by Oxford Bioscience III Corporation
Korea-Seoul Life Science Fund no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners II L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners (bermuda) III Limited Partnership no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners (gs-Adjunct) II L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Mrna Fund L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners II Annex L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Oxford Bioscience Partners III L.P. no longer reported on Form ADV by Oxford Bioscience III Corporation
Mrna Fund II L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $1,046,802
Oxford Bioscience Partners IV L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $95,897,035
Oxford Bioscience Partners III L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $3,835,484
Oxford Bioscience Partners II Annex L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $2,566,154
Mrna Fund V L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $2,617,706
Oxford Bioscience Partners II L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $13,016,225
Oxford Bioscience Partners (adjunct) II L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $2,495,672
Oxford Bioscience Partners (bermuda) II Limited Partnership first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $9,575,121
Oxford Bioscience Partners (bermuda) III Limited Partnership first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $654,662
Oxford Bioscience Partners (adjunct) III L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $217,551
Korea-Seoul Life Science Fund first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $63,991,158
Oxford Bioscience Partners V L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $114,132,710
Oxford Bioscience Partners (gs-Adjunct) II L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $4,073,807
Mrna Fund L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $29,245